Home / Companies / Shenzhen Goodwind Technology Development Co., Ltd.

Shenzhen Goodwind Technology Development Co., Ltd.

3 FDA records filed under this company name, from 2022 to 2026, in light for wrinkles (OHS, 2), hair removal (OHT, 1).

The applicant is the company that filed with FDA. It can be the brand you know or a manufacturer that makes devices sold under other brand names; the device name as filed often shows which. We don't merge different company names, so check the A–Z list for related entries.

LED and light devices for wrinkles (OHS, 2)

510(k) clearedAug 10, 2026

Eye Recovery Pro (PH-e03)

510(k) number: K261602
Applicant: Shenzhen Goodwind Technology Development Co., Ltd.
Product code: OHS: Light Based Over The Counter Wrinkle Reduction
Regulation: 21 CFR 878.4810, Class II
FDA decision: Substantially Equivalent (SESE)
Received: May 14, 2026

Indications for use

Not quoted here. We couldn't find a clean, complete statement in FDA's PDF, so we don't quote one. Read FDA's PDF.

FDA database record FDA document (PDF)

510(k) clearedDec 17, 2025

Wrinkle Retreat Pro Light Therapy Face Mask (Model: PH-m03)

510(k) number: K252983
Applicant: Shenzhen Goodwind Technology Development Co., Ltd.
Product code: OHS: Light Based Over The Counter Wrinkle Reduction
Regulation: 21 CFR 878.4810, Class II
FDA decision: Substantially Equivalent (SESE)
Received: Sep 18, 2025

Indications for use, as filed

“The Wrinkle Retreat Pro Light Therapy Face Mask is an Over-the-Counter (OTC) device intended for use in treating fullface wrinkles.”

Copied from the text of FDA's 510(k) document (PDF, page 4), with line breaks removed.

FDA database record FDA document (PDF)

Laser and IPL hair removal (mostly over-the-counter; 1 record says prescription use) (OHT, 1)

510(k) clearedSep 28, 2022

IPL Hair Removal Device

510(k) number: K222316
Applicant: Shenzhen Goodwind Technology Development Co., Ltd.
Product code: OHT: Light Based Over-The-Counter Hair Removal
Regulation: 21 CFR 878.4810, Class II
FDA decision: Substantially Equivalent (SESE)
Received: Aug 2, 2022

Indications for use

Not quoted here. The page with this statement is a scanned image whose text was machine-read, so we can't vouch for it word for word. Read FDA's PDF, page 3.

FDA database record FDA document (PDF)